 | Up a level |
Article
Dodou, Kalliopi, Armstrong, Andrew, Kelly, Ivan, Wilkinson, Simon, Carr, Kevin, Shattock, Paul and Whiteley, Paul (2014) Ex vivo studies for the passive transdermal delivery of low dose naltrexone from a cream; detection of naltrexone and its active metabolite, 6β-naltrexol, using a novel LC Q-ToF MS assay. Pharmaceutical Development and Technology, 20 (6). pp. 694-701. ISSN 1083-7450
Whitlel, P, Todd, Lynda, Dodou, Kalliopi and Shattock, Paul (2009) Trends in Developmental, Behavioural and Somatic Factors by Diagnostic Sub-Group in Pervasive Developmental Disorders: A Follow up Analysis. Autism Insights, 1. pp. 3-17. ISSN 1179-5964
Whiteley, P, Waring, R, Williams, Lee, Klovrza, L, Nolan, F, Smith, S, Farrow, M, Dodou, Kalliopi, Lough, John and Shattock, Paul (2006) Spot urinary creatinine excretion in pervasive developmental disorders. Pediatrics International, 48 (3). 292-297.. ISSN 1442-200X
Anderson, Rosaleen, Bendell, David, Garnett, Ian, Groundwater, Paul, Lough, John and Shattock, Paul (2002) Identification of Indolyl-3-acryloylglycine (IAcrGly) in the Urine of People with Autism. Journal of Pharmacy and Pharmacology, 54 (2). pp. 295-298. ISSN 00223573